But wait, there's more:
"Mar 08 2024 – Broker Rating Changes
POLYNOVO LIMITED ((PNV)) Upgrade to Overweight from Market Weight by Wilsons
Wilsons upgrades its rating for PolyNovo to Overweight from Market Weight and raises its target to $2.44 from $1.79 following a 19% revenue beat in the 1H.
The broker feels the company's position within the US surgeon base has been solidified, particularly for large, difficult to treat burns.
In a rare feat relative to med-tech peers, note the analysts, PolyNovo's expansion outside of the US has progressed to the extent 25% of revenue is now derived from rest-of-the-world (ROW) markets. At the same time, gross margins have held at 95%." LINK
But wait, there's more:"Mar 08 2024 – Broker Rating...
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.27 |
Change
0.060(2.71%) |
Mkt cap ! $1.566B | |||
| Open | High | Low | Value | Volume |
| $2.27 | $2.30 | $2.24 | $2.204M | 970.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 16437 | $2.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.28 | 1117 | 1 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.28 |
Change
0.060 ( 3.04 %) |
||||
| Open | High | Low | Volume | ||
| $2.26 | $2.29 | $2.24 | 339564 | ||
| Last updated 15.59pm 06/06/2024 ? | |||||
| PNV (ASX) Chart |